Authors: NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J FREDERICK L SULEYMANOV O KING L PAGE J FEIGEN L

Citation: N. Nicholson et al., BIOLOGICAL-ACTIVITY OF ORBOFIBAN, AN ORALLY-ACTIVE INHIBITOR OF GLYCOPROTEIN IIB IIIA AND PLATELET-AGGREGATION/, Thrombosis and haemostasis, 1997, pp. 2719-2719

Authors: BARON DA FEIGEN L MEYER B CHESEBRO J FUSTER V BADIMON L BADIMON JJ

Citation: Da. Baron et al., ORAL DOSING WITH THE GP-IIB IIIA RECEPTOR ANTAGONIST SC-54684A INHIBITS THE FORMATION OF PLATELET-RICH THROMBI ON DAMAGED CANINE AORTA MOUNTED IN AN EX-VIVO PERFUSION CHAMBER/, Thrombosis and haemostasis, 73(6), 1995, pp. 1332-1332

Authors: NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J ZABLOCKI J FEIGEN L GLENN K KELLER B BROSCHAT K HERIN M JACQMIN P LESNE M

Citation: N. Nicholson et al., AN ORALLY-ACTIVE GLYCOPROTEIN-IIB IIIA ANTAGONIST-SC-54684/, Thrombosis and haemostasis, 69(6), 1993, pp. 975-975

Authors: FEIGEN L NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J ZABLOCKI J GLENN K KELLER B HERIN M JACQMIN P LESNE M

Citation: L. Feigen et al., LONG-TERM INHIBITION OF PLATELETS IN DOGS WITH THE ORALLY-ACTIVE ALPHA(IIB)BETA(3) ANTAGONIST-SC-54684, Thrombosis and haemostasis, 69(6), 1993, pp. 1071-1071

Authors: ZABLOCKI J NICHOLSON N TAITE B PANZERKNODLE S SALYERS A HAAS N SZALONY J FEIGEN L HERIN M JACQMIN P LESNE M BOVY P TJOENG FS

Citation: J. Zablocki et al., SELECTION OF AN ORALLY-ACTIVE GLYCOPROTEIN-IIB IIIA RECEPTOR ANTAGONIST FOR CLINICAL-TRIALS/, Thrombosis and haemostasis, 69(6), 1993, pp. 1244-1244

Authors: CREASEY AA CHANG ACK FEIGEN L WUN TC TAYLOR FB HINSHAW LB

Citation: Aa. Creasey et al., TISSUE FACTOR PATHWAY INHIBITOR REDUCES MORTALITY FROM ESCHERICHIA-COLI SEPTIC SHOCK, The Journal of clinical investigation, 91(6), 1993, pp. 2850-2860